PATHOPHYSIOLOGICAL BASES OF OBESITY AND PREECLAMPSIA IN PREGNANCY AND THEIR IMPACT ON RENAL FUNCTION

Norsoatova Dilobar; Kholova Zarina

Vol. 4 No. 5 (2026), Articles

Vol. 4 No. 5 (2026)

PATHOPHYSIOLOGICAL BASES OF OBESITY AND PREECLAMPSIA IN PREGNANCY AND THEIR IMPACT ON RENAL FUNCTION

Articles

Published 2026-06-01

Norsoatova Dilobar⁺⁻
Kholova Zarina⁺⁻

Norsoatova Dilobar

First-Year Master's Candidate in the Department of Obstetrics and Gynecology, Termiz Branch, Tashkent State Medical University

Kholova Zarina

Scientific supervisor,PhD in medical sciencies, Termiz Branch, Tashkent State Medical University

PDF

DOI

Keywords

Obesity in pregnancy, Preeclampsia, Pathophysiology, Renal dysfunction, Glomerular hyperfiltration, Endothelial dysfunction, RAAS, Oxidative stress, Inflammation, Maternal outcomes.

How to Cite

PATHOPHYSIOLOGICAL BASES OF OBESITY AND PREECLAMPSIA IN PREGNANCY AND THEIR IMPACT ON RENAL FUNCTION. (2026). Yangi O’zbekistonda Tabiiy Va Ijtimoiy-Gumanitar Fanlar Respublika Ilmiy Amaliy Konferensiyasi, 4(5), 127-133. https://www.universalpublishings.com/index.php/gumanitar/article/view/18903

Abstract

Obesity during pregnancy is one of the most significant risk factors for maternal and fetal complications, with preeclampsia representing the most severe among them. The pathophysiological link between obesity and preeclampsia is complex, involving chronic low-grade inflammation, insulin resistance, endothelial dysfunction, and altered renal hemodynamics.

PDF

DOI

References

ACOG Practice Bulletin No. 222. (2020). Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology, 135(6), e237–e260.

2. Bhatt, D. L., Kannan, S., & Kumar, A. (2021). Obesity, inflammation, and preeclampsia: Mechanistic insights. Nature Reviews Nephrology, 17(5), 290–305.

3. Burton, G. J., Redman, C. W., Roberts, J. M., & Moffett, A. (2019). Pre-eclampsia: Pathophysiology and clinical implications. BMJ, 366, l2381.

4. Catalano, P. M., & Shankar, K. (2017). Obesity and pregnancy: Mechanisms of short term and long term adverse consequences for mother and child. BMJ, 356, j1.

5. Conrad, K. P., & Davison, J. M. (2014). The renal circulation in normal pregnancy and preeclampsia: Is there a place for relaxin? American Journal of Physiology – Renal Physiology, 306(10), F1121–F1135.

6. Hladunewich, M., Karumanchi, S. A., & Lafayette, R. (2007). Pathophysiology of the clinical manifestations of preeclampsia. Clinical Journal of the American Society of Nephrology, 2(3), 543–549.

7. Jeyabalan, A. (2013). Epidemiology of preeclampsia: Impact of obesity. Nutrition Reviews, 71(Suppl 1), S18–S25.

8. Lim, S. S., Vos, T., Flaxman, A. D., & Danaei, G. (2012). A comparative risk assessment of burden of disease attributable to 67 risk factors. The Lancet, 380(9859), 2224–2260.

9. Lu, H. Q., & Hu, R. (2019). The role of the immune system in the pathogenesis of preeclampsia. Frontiers in Immunology, 10, 1539.

10. Maynard, S. E., & Karumanchi, S. A. (2011). Angiogenic factors and preeclampsia. Seminars in Nephrology, 31(1), 33–46.

11. Powe, C. E., Levine, R. J., & Karumanchi, S. A. (2011). Preeclampsia, a disease of the maternal endothelium: The role of anti-angiogenic factors and implications for later cardiovascular disease. Circulation, 123(24), 2856–2869.

12. Roberts, J. M., & Hubel, C. A. (2009). The two stage model of preeclampsia: Variations on the theme. Placenta, 30(Suppl A), S32–S37.

13. Thadhani, R., Mutter, W. P., Wolf, M., & Levine, R. J. (2004). First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. Journal of Clinical Endocrinology & Metabolism, 89(2), 770–775.

14. Vasan, R. S. (2006). Biomarkers of cardiovascular disease: Molecular basis and practical considerations. Circulation, 113(19), 2335–2362.

15. Yung, H. W., Atkinson, D., Campion-Smith, T., Olovsson, M., Charnock-Jones, D. S., & Burton, G. J. (2014). Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early and late-onset pre-eclampsia. Journal of Pathology, 234(2), 262–276.